Buy Divis Lab, says Sanjay Vaid of SBI Capital.
Vaid told CNBC-TV18, "Buy Divis Lab. The stock had given a decent performance in quarter one. The PAT was up almost 19.5% and sales grew 36% year-on-year, clearly showing good traction coming in the company. The strong growth projection given by the management gives us lot of comfort in the stock and the managementDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!